fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25. Recall
Ongoing
Drugs
Class II — Moderate
Recall Date
May 6, 2026
Company
Wells Pharma of Houston LLC
Source
FDA
Units
50 syringes
Reason: cGMP deviations.
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Recall Details
Description
cGMP deviations.
Reason for Recall
cGMP deviations.
What Should I Do?
Quantity: 50 syringes
Remediation GuideAction Required
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
1
Confirm Your Product Is Affected2
Read the Full Recall Notice3
Stop Using the Product if in Doubt+2 more steps…
Last updated May 12, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.